Cargando…
Clinical applications of mesenchymal stem cells in chronic lung diseases
Mesenchymal stem (stromal) cells (MSCs) are multipotent stromal cells that have the ability to modulate immune response to tissue injury and promote repair in vivo. The therapeutic potential of ex vivo expanded MSCs are currently under investigation for a variety of chronic and acute lung diseases....
Autores principales: | Antoniou, Katerina M., Karagiannis, Konstantinos, Tsitoura, Eliza, Bibaki, Eleni, Lasithiotaki, Ismini, Proklou, Athanasia, Spandidos, Demetrios A., Tzanakis, Nikos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844081/ https://www.ncbi.nlm.nih.gov/pubmed/29556380 http://dx.doi.org/10.3892/br.2018.1067 |
Ejemplares similares
-
Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP
por: Antoniou, Katerina M, et al.
Publicado: (2012) -
MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells
por: Tsitoura, Eliza, et al.
Publicado: (2016) -
NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer
por: Lasithiotaki, Ismini, et al.
Publicado: (2018) -
Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients
por: Karagiannis, K., et al.
Publicado: (2017) -
miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns
por: Bibaki, Eleni, et al.
Publicado: (2018)